Acella recalls thyroid drug for subpotency

Acella Pharmaceuticals is recalling two lots of its thyroid drugs due to subpotency, the Alpharetta, Ga.-based drugmaker said Sept. 17. 

The drug may contain as little as 87 percent of the amount of levothyroxine the label says it has, Acella said. Levothyroxine is used to treat hypothyroidism, a condition in which thyroid glands don’t produce enough of certain crucial hormones. It can cause a number of health problems, such as obesity, joint pain, infertility and heart disease, according to Rochester, Minn.-based Mayo Clinic

Patients taking the drug to treat hypothyroidism may experience symptoms including fatigue, slow heart rate, depression and swelling of the thyroid gland. There is a risk of serious injury in newborn infants or pregnant women with hypothyroidism who take the drug. Elderly patients and patients with underlying cardiac disease may experience cardiac pain, palpitations or cardiac arrhythmia, Acella said. 

Acella has received four reports of adverse events that it says are possibly related to the recall. 

Read the full news release here

More articles on pharmacy:
Drug costs surge faster than any other medical good or service, data shows
Eli Lilly, Amgen partner to make Lilly’s COVID-19 antibody drug
Moderna will know if COVID-19 vaccine is effective in November, CEO says


© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.